The purpose of this resolution is to advocate for the inclusion of antiphospholipid syndrome (APS) testing as a routine part of prenatal screening for pregnant women. The resolution highlights the importance of identifying APS early, as it can lead to serious complications during pregnancy, including miscarriages and stillbirths. Key provisions of the resolution express support for APS testing to be recognized as a standard practice in prenatal care.